Home Healthcare Pharmaceuticals Injectable Drugs Market

Injectable Drugs Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Drug Class (Blood Factors, Cytokines, Peptide Hormone, Immunoglobulin, Monoclonal Antibodies (MABS), Insulin, Other Drug Classes), By Applications (Oncology, Neurology, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Pain, Other Applications) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Jay Mehta | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Injectable Drugs Market, By Molecule Type 2022-2034 (USD MILLION/ Units)
    1. Small Molecule
    2. Large Molecule
  2. Injectable Drugs Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Blood Factors
    2. Cytokines
    3. Peptide Hormone
    4. Immunoglobulin
    5. Monoclonal Antibodies (MABS)
    6. Insulin
    7. Other Drug Classes
  3. Injectable Drugs Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Neurology
    3. Cardiovascular Diseases
    4. Autoimmune Diseases
    5. Infectious Diseases
    6. Pain
    7. Other Applications
  4. Regional Injectable Drugs Market
    1. North America
      1. North America Injectable Drugs Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      2. North America Injectable Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Blood Factors
        2. Cytokines
        3. Peptide Hormone
        4. Immunoglobulin
        5. Monoclonal Antibodies (MABS)
        6. Insulin
        7. Other Drug Classes
      3. North America Injectable Drugs Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiovascular Diseases
        4. Autoimmune Diseases
        5. Infectious Diseases
        6. Pain
        7. Other Applications
      4. U.S.
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      5. Canada
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
    2. Europe
      1. Europe Injectable Drugs Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      2. Europe Injectable Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Blood Factors
        2. Cytokines
        3. Peptide Hormone
        4. Immunoglobulin
        5. Monoclonal Antibodies (MABS)
        6. Insulin
        7. Other Drug Classes
      3. Europe Injectable Drugs Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiovascular Diseases
        4. Autoimmune Diseases
        5. Infectious Diseases
        6. Pain
        7. Other Applications
      4. U.K.
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      5. Germany
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      6. France
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      7. Spain
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      8. Italy
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      9. Russia
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      10. Nordic
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      11. Benelux
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      12. Rest of Europe
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
    3. APAC
      1. APAC Injectable Drugs Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      2. APAC Injectable Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Blood Factors
        2. Cytokines
        3. Peptide Hormone
        4. Immunoglobulin
        5. Monoclonal Antibodies (MABS)
        6. Insulin
        7. Other Drug Classes
      3. APAC Injectable Drugs Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiovascular Diseases
        4. Autoimmune Diseases
        5. Infectious Diseases
        6. Pain
        7. Other Applications
      4. China
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      5. Korea
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      6. Japan
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      7. India
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      8. Australia
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      9. Taiwan
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      10. South East Asia
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      11. Rest of Asia-Pacific
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
    4. Middle East and Africa
      1. Middle East and Africa Injectable Drugs Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      2. Middle East and Africa Injectable Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Blood Factors
        2. Cytokines
        3. Peptide Hormone
        4. Immunoglobulin
        5. Monoclonal Antibodies (MABS)
        6. Insulin
        7. Other Drug Classes
      3. Middle East and Africa Injectable Drugs Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiovascular Diseases
        4. Autoimmune Diseases
        5. Infectious Diseases
        6. Pain
        7. Other Applications
      4. UAE
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      5. Turkey
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      6. Saudi Arabia
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      7. South Africa
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      8. Egypt
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      9. Nigeria
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      10. Rest of MEA
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
    5. LATAM
      1. LATAM Injectable Drugs Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      2. LATAM Injectable Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Blood Factors
        2. Cytokines
        3. Peptide Hormone
        4. Immunoglobulin
        5. Monoclonal Antibodies (MABS)
        6. Insulin
        7. Other Drug Classes
      3. LATAM Injectable Drugs Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurology
        3. Cardiovascular Diseases
        4. Autoimmune Diseases
        5. Infectious Diseases
        6. Pain
        7. Other Applications
      4. Brazil
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      5. Mexico
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      6. Argentina
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      7. Chile
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      8. Colombia
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
      9. Rest of LATAM
        1. Small Molecule
        2. Large Molecule
        3. Blood Factors
        4. Cytokines
        5. Peptide Hormone
        6. Immunoglobulin
        7. Monoclonal Antibodies (MABS)
        8. Insulin
        9. Other Drug Classes
        10. Oncology
        11. Neurology
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Infectious Diseases
        15. Pain
        16. Other Applications
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.